NCT07416812 2026-02-18
IMPACT
Institute of Oncology Ljubljana
Phase NA Completed
Clinical Trials
13 trialsNCT04706663 2026-02-17
Precision-Based Genomics in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Recruiting
NCT06636526 2026-02-04
The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
Institute of Cancer Research, United Kingdom
Recruiting
NCT00848289 2026-01-14
Genetic Susceptibility to Bladder Cancer
M.D. Anderson Cancer Center
Active not recruiting
NCT04763317 2025-12-16
PMPRC
Institute of Cancer Research, United Kingdom
Recruiting
NCT06659614 2025-11-05
PTBB
Abramson Cancer Center at Penn Medicine
Recruiting
NCT00261456 2025-09-26
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
Institute of Cancer Research, United Kingdom
Active not recruiting
NCT03934606 2025-04-10
Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model
Abramson Cancer Center at Penn Medicine
Completed
NCT06470685 2025-03-27
PPPC
Royal Marsden NHS Foundation Trust
Enrolling by invitation
NCT05129605 2024-10-09
PROGRESS
Massachusetts General Hospital
Recruiting
NCT04873427 2023-02-15
In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies
Clinica Luganese Moncucco
Terminated
NCT05681416 2023-01-12
ProFam-Risk
Heinrich-Heine University, Duesseldorf
Phase NA Not yet recruiting
NCT00341861 2020-10-22
Interdisciplinary Case-Control Study of Bladder Cancer in Spain
National Institutes of Health Clinical Center (CC)
Completed